glp-1 gip mechanism of action Major physiological roles and GIP. Tirzepatide is acting as an GLP-1: Actions on Beta-cell Mass

Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer

Taking GLP-1s has been shown to reduce markers of inflammation

Diabetologia 66 (10), 18201831

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

According to ASMBS/IFSO guidelines, surgery may be considered for patients with BMI 40 kg/m or BMI 35 kg/m with obesity-related complications

Synovial inflammation in osteoarthritis progression